Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer.
Naoki TeradaTakashi MizowakiToshihiro SaitoAkira YokomizoNaoki KoheiKen-Ichi TabataMasaki ShiotaAtsushi TakahashiToru ShimazuiTakayuki GotoYasuhiro HashimotoMasato FujiiRyotaro TomidaToshihiko SakuraiKohei HashimotoSadafumi KawamuraShogo TeraokaShinichi SakamotoTakahiro KimuraManabu KamiyamaShintaro NaritaNobumichi TanakaTakuma KatoMasashi KatoTakahiro OsawaTakahiro KojimaTakahiro InoueMikio SugimotoHiroyuki NishiyamaToshiyuki Kamotonull nullPublished in: BJUI compass (2020)
Addition of local RT to standard treatment for de novo metastatic prostate cancer patients tends to have the potential to extend survival, even in patients with high metastatic burden, and to reduce SLEs.